Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
Clinical trial NCT01242267 · COMPLETED
Trial details
- NCT number
- NCT01242267
- Sponsor
- Hackensack Meridian Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-11
- Primary completion
- 2016-01-20
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.